JUPITER is an observational study protocol that aims to understand factors that can help prevent/mitigate the spread of COVID-19 and understand factors that help reduce disease progression in patients with COVID-19. We aim to accomplish this by obtaining self-reported historical and longitudinal data from study participants.
This is an observational study that will electronically collect self-reported participant
data in a database that follows HIPAA security requirements for those with a clinically
confirmed case of COVID-19 or those who have had exposure to COVID-19.
The aim of this study is to gather a large, diverse dataset from a large population of
participants in order to gather longitudinal observational data on what health practices
participants are practicing and what, if any, benefits these practices may be providing the
participants.
Data for this study will be gathered via self-reporting from participants who wish to
participate in the fight against COVID-19. This will include getting a baseline of each
participant's health and then monitor their health over time while looking at how their
symptoms are progressing or regressing. The JUPITER study may also seek historical data from
patients who have recovered from COVID-19.
The JUPITER dataset may be shared (in accordance with applicable state, federal, and local
laws) so that others may utilize the data from the dataset for further analysis to determine
relevant trends in the data and in turn hopefully use these trends to determine potential
treatment protocols or lifestyle recommendations to help prevent COVID-19 spread and reduce
hospitalization rates, as well as to understand how certain factors may aide in the COVID-19
disease progression.
Inclusion Criteria:
1. Adults residing in the United States aged 18 years or older proficient in
understanding and reading the English language who wish to participate in the fight
against COVID-19 by providing self-reported health information.
2. Ability to complete electronic informed consent process.
3. Ability to use the internet and check email regularly.
4. Consent to provide a HIPAA waiver of health information to share protected health
information.
Exclusion Criteria:
1. Inability to provide regular updates to their health status when contacted by the BEAT
COVID study personnel via email or SMS.
Beat COIVD, LLC
Chicago, Illinois, United States
Rama Jager, M.D.
(708) 620-4608
rjager@beatcovidtrial.com
Hollis Ledbetter
hledbetter@beatcovidtrial.com